C9orf72 and amyotrophic lateral sclerosis: The therapy developer reported that this CRISPR‐based gene therapy significantly reduced the accumulation of toxic RNA molecules resulting from C9orf72 repeat mutations in cells and ALS mouse models without affecting the levels of healthy C9orf72 RNA (Fang et al. 2022).